2.25
                                            Schlusskurs vom Vortag:
              $2.57
            Offen:
              $2.09
            24-Stunden-Volumen:
                250.46K
            Relative Volume:
              0.10
            Marktkapitalisierung:
                $4.31M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-5.00M
            KGV:
              -1.9565
            EPS:
                -1.15
            Netto-Cashflow:
                $-3.85M
            1W Leistung:
              -24.50%
            1M Leistung:
              -31.61%
            6M Leistung:
                -28.22%
            1J Leistung:
              -73.58%
            Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Firmenname
                  
                      Protagenic Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (212) 994-8200
                    
                Adresse
                  
                      149 FIFTH AVENUE, NEW YORK
                    
                Vergleichen Sie PTIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                PTIX
                            
                             
                        Protagenic Therapeutics Inc 
                           | 
                    2.25 | 4.95M | 0 | -5.00M | -3.85M | -1.15 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Protagenic Therapeutics Inc Aktie (PTIX) Neueste Nachrichten
Chart overlay techniques for tracking Protagenic Therapeutics Inc.Quarterly Profit Review & Community Consensus Trade Signals - newser.com
Visualizing Protagenic Therapeutics Inc. Equity Warrant stock with heatmapsPortfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
Will Protagenic Therapeutics Inc. (MBP0) stock boost dividends further2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
Protagenic Therapeutics Inc. stock prediction for this weekSwing Trade & Safe Investment Capital Preservation Plans - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock a buy before product launchesBond Market & Stepwise Entry/Exit Trade Alerts - newser.com
Why Protagenic Therapeutics Inc. (MBP0) stock benefits from AI revolutionJobs Report & Verified Swing Trading Watchlist - newser.com
Is Protagenic Therapeutics Inc. (MBP0) stock in buy zone after pullback2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com
How Protagenic Therapeutics Inc. (MBP0) stock behaves in tightening cyclesGold Moves & Short-Term Swing Trade Alerts - newser.com
Why Protagenic Therapeutics Inc. (MBP0) stock could be next leaderJuly 2025 Catalysts & Community Trade Idea Sharing Platform - newser.com
Sentiment analysis tools applied to Protagenic Therapeutics Inc.Market Performance Summary & Weekly High Conviction Ideas - newser.com
Can Protagenic Therapeutics Inc. Equity Warrant stock attract ESG capital inflowsMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Using R and stats models for Protagenic Therapeutics Inc. Equity Warrant forecasting2025 Volatility Report & Community Shared Stock Ideas - newser.com
Why Protagenic Therapeutics Inc. (MBP0) stock is favored by hedge fundsEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Will Protagenic Therapeutics Inc. Equity Warrant rebound enough to break evenWeekly Profit Report & Growth Focused Entry Reports - newser.com
What technical charts say about Protagenic Therapeutics Inc. stockMarket Volume Report & High Win Rate Trade Alerts - newser.com
How Protagenic Therapeutics Inc. Equity Warrant stock performs in rising dollar environmentPortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
Visual trend scoring systems applied to Protagenic Therapeutics Inc.Trade Risk Report & Free High Return Stock Watch Alerts - newser.com
Relative strength of Protagenic Therapeutics Inc. Equity Warrant in sector analysisJuly 2025 Intraday Action & Free Fast Gain Swing Trade Alerts - newser.com
Will Protagenic Therapeutics Inc. stock beat EPS estimatesJuly 2025 WrapUp & Daily Volume Surge Trade Alerts - newser.com
How Protagenic Therapeutics Inc. (MBP0) stock performs in easing cyclesJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com
Why Protagenic Therapeutics Inc. stock could see breakout soonRate Hike & Low Risk Entry Point Tips - newser.com
Real time social sentiment graph for Protagenic Therapeutics Inc.Trend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock trading near support levelsJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
How to monitor Protagenic Therapeutics Inc. with trend dashboards2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Real time pattern detection on Protagenic Therapeutics Inc. Equity Warrant stockTrade Volume Summary & Growth Focused Entry Point Reports - newser.com
Why Protagenic Therapeutics Inc. is moving todayTrade Exit Summary & Weekly High Return Forecasts - newser.com
Protagenic Therapeutics Inc. Equity Warrant stock chart pattern explainedJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
Why Protagenic Therapeutics Inc. (MBP0) stock could be top winner2025 Year in Review & Scalable Portfolio Growth Ideas - newser.com
Why retail traders accumulate Protagenic Therapeutics Inc. (MBP0) stockWeekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock attractive after correctionProfit Target & Safe Capital Growth Plans - newser.com
Will Protagenic Therapeutics Inc. (MBP0) stock enhance shareholder valueJuly 2025 Reactions & Long-Term Growth Plans - newser.com
Will Protagenic Therapeutics Inc. rebound enough to break evenMarket Growth Summary & Long-Term Safe Investment Ideas - newser.com
What sentiment indicators say about Protagenic Therapeutics Inc. Equity Warrant stockJuly 2025 Catalysts & Community Trade Idea Sharing Platform - newser.com
How Protagenic Therapeutics Inc. Equity Warrant stock benefits from strong dollarJuly 2025 Chart Watch & Community Trade Idea Sharing Platform - newser.com
Can Protagenic Therapeutics Inc. stock maintain operating marginsWeekly Trend Recap & Step-by-Step Swing Trade Plans - newser.com
How dovish Fed policy supports Protagenic Therapeutics Inc. (MBP0) stock2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com
Published on: 2025-11-02 07:11:02 - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock attractive for hedge fundsJuly 2025 Review & Technical Analysis for Trade Confirmation - newser.com
Cash per share of Protagenic Therapeutics, Inc. Warrant 2021-26.04.26 on Protagenic Thera – NASDAQ:PTIXW - TradingView
Finanzdaten der Protagenic Therapeutics Inc-Aktie (PTIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):